Table 3.
Phase | Holes in Negative Lid | Sensitivity Required to Advance |
Specificity Required to Advance |
Minimum # Sessions Required to Advance |
# COVID-19 (+) Samples/Session | # COVID-19 (-) Samples/Session |
---|---|---|---|---|---|---|
Imprinting | 1 | 9/10 trials overall correct | 1 | 1 | 1 | |
Phase 1 | 1 | 80% (5/6 correct) |
80% (10/12 correct) |
3 in a row | 2 | 4 |
Phase 2 | 4 | 80% (5/6 correct) |
80% (10/12 correct) |
3 in a row | 2 | 4 |
Phase 3 | 16 | 80% (5/6 correct) |
80% (10/12 correct) |
3 in a row | 2 | 4 |
Phase 4 | Fully open | 80% (5/6 correct) |
80% (10/12 correct) |
3 in a row | 2 | 4 |
Sensitivity = TP/(TP + FN) Rate of alert to positive samples Specificity = TN/(FP + TN) Rate of no alert to negative/blank samples |